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Abstract22
Nuclear Magnetic Resonance (NMR) spectra are widely used in metabolomics to23
obtain profiles of metabolites dissolved in biofluids such as cell supernatants. Methods24
for estimating metabolite concentrations from these spectra are presently confined to25
manual peak fitting and to binning procedures for integrating resonance peaks. Exten-26
sive information on the patterns of spectral resonance generated by human metabo-27
lites is now available in online databases. By incorporating this information into a28
Bayesian model we can deconvolve resonance peaks from a spectrum and obtain ex-29
plicit concentration estimates for the corresponding metabolites. Spectral resonances30
that cannot be deconvolved in this way may also be of scientific interest so we model31
them jointly using wavelets.32
We describe a Markov chain Monte Carlo algorithm which allows us to sample from33
the joint posterior distribution of the model parameters, using specifically designed34
block updates to improve mixing. The strong prior on resonance patterns allows the35
algorithm to identify peaks corresponding to particular metabolites automatically,36
eliminating the need for manual peak assignment.37
We assess our method for peak alignment and concentration estimation. Except38
in cases when the target resonance signal is very weak, alignment is unbiased and39
precise. We compare the Bayesian concentration estimates to those obtained from40
a conventional numerical integration method and find that our point estimates have41
sixfold lower mean squared error.42
Finally, we apply our method to a spectral dataset taken from an investigation43
of the metabolic response of yeast to recombinant protein expression. We estimate44
the concentrations of 26 metabolites and compare to manual quantification by five45
expert spectroscopists. We discuss the reason for discrepancies and the robustness of46
our methods concentration estimates.47
Keywords: metabolomics, concentration estimation, prior information, multi com-48
ponent model, block updates.49
4
1. INTRODUCTION50
Metabolomics (also known as metabonomics or sometimes metabolic profiling) is a51
scientific discipline concerned with the quantitative study of metabolites, the small52
molecules that participate in metabolic reactions. Research in this field is expanding53
rapidly, with applications in many areas of biology and medicine including cancer54
(e.g. Griffiths et al. (2002)), toxicology (e.g. Lindon et al. (2003)), organism clas-55
sification (e.g. Bundy et al. (2002)), genetics (e.g. Illig et al. (2010)), biochemistry56
(e.g. Raamsdonk et al. (2001)), epidemiology (e.g. Holmes et al. (2008)) and disease57
diagnostics (e.g. Brindle et al. (2002)).58
Almost all experiments in metabolomics rely on measurements of the abundances59
of metabolites in complex biological mixtures, often biofluid or tissue samples. One60
of the most extensively used techniques for obtaining such quantitative information61
is proton nuclear magnetic resonance (1H NMR) spectroscopy. Metabolites generate62
characteristic resonance signatures in 1H NMR spectra and each signature appears63
with intensity proportional to the concentration of the corresponding metabolite in64
the biological mixture.65
Specialized models and tools are needed to draw inferences from 1H NMR spec-66
troscopic datasets, which are large and heavily structured. At present there is no67
statistical method for analyzing metabolomic NMR spectra reflecting the data gen-68
erating mechanisms and the extensive prior knowledge available, e.g. on the form of69
metabolite NMR signatures. In this paper, we describe novel Bayesian approaches for70
the analysis of 1H NMR data from complex biological mixtures. Specifically, we de-71
velop new models reflecting the data generation mechanisms and our prior knowledge,72
using a combination of parametric functions and wavelets. We introduce a computa-73
tional strategy based on Markov chain Monte Carlo (MCMC), including novel block74
updates to overcome strong posterior correlation between the parametric functions75
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and the wavelets. We demonstrate the utility of the approach with simulations and76
analyses of data from a yeast metabolomics experiment.77
1.1 NMR spectroscopy78
An NMR spectrum consists of a series of measurements of resonance intensity usu-79
ally taken on a grid of equally spaced frequencies. Figure 1 is a representative sec-80
tion (of about one tenth) of an NMR spectrum taken from an experiment into the81
metabolomic response of yeast to recombinant protein expression. The x-axis of the82
spectrum corresponds to resonant frequency and the y-axis to resonance intensity.83
[Figure 1 about here.]84
The spectrum is a collection of convolved peaks with different horizontal positions85
and vertical scalings, each of which has the form of a Lorentzian curve. The zero86
centered, standardized Lorentzian function takes the form87
lγ(x) =
2
pi
γ
4x2 + γ2
. (1)
This is the pdf of a Cauchy distribution with scale parameter γ/2; in spectroscopy γ88
is called the peak-width at half-height (or sometimes the linewidth).89
Each spectral peak corresponds to magnetic nuclei resonating at a particular fre-90
quency in the biological mixture. This frequency determines the displacement of the91
peak on the x-axis, which is known as its chemical shift and is measured in parts92
per million (ppm) of the resonant frequency of a standard peak. It is conventional93
in NMR spectroscopy to use δ to denote chemical shift and for the δ-axis to increase94
from right to left. 1H NMR only detects the resonance of hydrogen nuclei and a95
typical 1H NMR spectrum has a range of about 0ppm-10ppm.96
The resonant frequencies of a magnetic nucleus are largely determined by its97
molecular environment, that is the chemical structure of the molecule in which it is98
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embedded and the configuration of its chemical bonding within the molecule. Con-99
sequently, every metabolite has a characteristic molecular 1H NMR signature, a con-100
volution of Lorentzian peaks that appear in specific positions in 1H NMR spectra.101
These are the peaks observed in the 1H NMR spectrum of a pure solution of the102
metabolite. The peaks of a signature can have quite different chemical shifts (when103
they are generated by protons with different bonding configurations) and so appear104
widely separated in a spectrum.105
Depending on its molecular environment, a proton may have more than one res-106
onant frequency and when this happens the frequencies are usually very similar.107
Consequently, the peaks generated appear in a spectrum as a juxtaposition called a108
multiplet. The shape of a multiplet (number of peaks, their separations and relative109
heights) can be used to identify the corresponding metabolite. Figure 2 shows an110
1H NMR spectrum (top panel) and the resonance signatures of the four metabolites111
contributing the principal resonance signals (lower panels), with characteristic peak112
locations and multiplet shapes.113
[Figure 2 about here.]114
The intensity of a nuclear magnetic signal is proportional to the number of mag-115
netically equivalent nuclei generating the resonance in the biological mixture. Conse-116
quently, every resonance peak (and therefore also every metabolite resonance signa-117
ture) scales vertically in a spectrum in proportion to the molecular abundance of the118
corresponding compound in the mixture.119
1.2 Specific challenges of NMR in metabolomics120
Biofluids and tissue samples usually contain thousands of metabolites. However,121
NMR is relatively insensitive, so that ordinarily a spectrum contains quantitative in-122
formation on just a few hundred of the most abundant compounds. These compounds123
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can generate hundreds of resonance peaks in a spectrum, many of which overlap.124
To quantify a collection of metabolites using NMR, at least one resonance peak125
generated by each compound must be identified in the spectrum and deconvolved.126
(To reduce uncertainty, it is desirable to identify as many peaks as possible for each127
compound.) Estimates of the relative concentrations of the metabolites in the bio-128
logical sample can be made by comparing the areas under the deconvolved resonance129
peaks. (Estimates of absolute concentration require a reference compound).130
The peak identification step (assignment) is complicated by fluctuations in peak131
positions between spectra, caused by uncontrollable differences in experimental con-132
ditions and differences in the chemical properties of the biological samples, such as133
the pH and ionic strength. When this positional noise combines with peak overlap,134
assignment can become very hard indeed.135
[Figure 3 about here.]136
The left panel of Figure 3 illustrates the problem. Excerpts from two spectra corre-137
sponding to biological replicates from the same experiment are overlaid, focusing on a138
doublet type multiplet with two peaks. The difference in peak position between repli-139
cates is obvious to the eye. Here, the magnitude of the positional noise is insufficient to140
confuse assignment by an expert spectroscopist but it will pose problems for standard141
automated approaches. However, expert deconvolution is rarely practical because it142
is labor intensive and relies on someone familiar with metabolite resonance patterns.143
Targeted profiling (Weljie et al. 2006) against a standard library of metabolite reso-144
nance peaks reduces the importance of expert knowledge but is slow because there is145
no automated fitting procedure. Spectral binning (Holmes et al. (1994), Spraul et al.146
(1994)) approaches divide the spectrum into regions (bins), within which the inten-147
sity measurements are averaged, in an attempt to isolate distinct resonance signals.148
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Although this mitigates the effect of peaks fluctuating position within bins, fluctu-149
ations across bin boundaries will cause anti-correlated increase/decrease of average150
intensity in adjacent bins, even if there is no associated change in metabolite concen-151
tration. Spectral binning balances parsimony and computational efficiency, retaining152
quantitative information but in a representation with many fewer, easy to compute,153
variables. However, the reduced variables are often analyzed without explicit quantifi-154
cation of individual metabolites using pattern recognition methods such as principal155
components analysis and partial least squares (Lindon, Holmes and Nicholson 2001).156
The additional complication of positional noise combined with peak overlap is157
illustrated in the right panel of Figure 3. The well defined resonance peaks overlap158
with broad signals attributable to a combination of closely overlapping low metabolite159
signals and/or macromolecular signatures. This introduces the problem of estimating160
the proportion of the signal associated with the sharp resonances and the propor-161
tion due to the broad component. The problem becomes even more complex when162
the target peaks also overlap with other sharp metabolite signals which additionally163
fluctuate between different spectra.164
Currently, there is no statistical methodology that can simultaneously address the165
problems of identification, deconvolution and quantification when there is positional166
noise and peak overlap. We believe a method based on explicit quantification from167
deconvolution of metabolite signatures should have significant advantages: spectral168
convolution models are parsimonious because they correspond to the physical process169
generating the data; the variables inferred are interpretable because they represent170
concentrations of identified metabolites; these concentrations are of direct scientific171
interest because they depend on the underlying biology.172
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1.3 Contributions of this paper173
To tackle the problem of quantifying metabolites in complex biofluids such as cell su-174
pernatants or urine, we present a Bayesian model for 1H NMR spectra and a Markov175
chain Monte Carlo (MCMC) algorithm to automate peak assignment and spectral176
deconvolution. Bayesian models for NMR data have been described before, notably177
in Bretthorst (1990a), in Bretthorst (1990b), in many subsequent papers by the same178
author, in Dou and Hodgson (1996) and in Rubtsov and Griffin (2007). Our modeling179
exploits extensive prior information on the resonance signatures of the metabolites,180
including the expected horizontal displacements and relative vertical scalings of the181
peaks. This novel approach allows us to deconvolve peaks and assign them to specific182
metabolites in a unified analysis, which eliminates the need for a manual assign-183
ment step. The prior information comes from the physical theory of NMR and from184
experimental information. Experimental resonance data on human metabolites are185
extensive and are publicly available, for example from the online database of the186
Human Metabolome Project, the HMDB (Wishart et al. 2009).187
Almost all biofluid and tissue NMR spectra contain peaks for which there is no188
prior information in the presently incomplete public metabolite databases. Despite189
this, the component of a spectrum that cannot be assigned to known compounds,190
may contain metabolomic information that is scientifically useful, e.g. for classifica-191
tion of spectra. We therefore propose a two component joint model for a spectrum.192
We model the metabolites whose peaks we wish to assign explicitly parametrically,193
using information from the online databases, while we model the unassigned spec-194
trum semi-parametrically, using wavelets. We choose wavelets because they model195
signal continuously but locally. They can account for the local correlation of a spec-196
trum caused by the continuity of the underlying physical processes without imposing197
unrealistic global modeling constraints.198
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The wavelet component of our two component likelihood is extremely flexible199
so that, without restriction, it tends to absorb signal that should be modeled by200
the parametric component, thus inducing a lack of identifiability. We address this201
by penalizing the wavelet coefficients using heavy-tailed scale-mixture priors. These202
priors shrink wavelet coefficients wherever the spectral signal can be explained by203
the parametric component of the model. We also impose a truncation condition on204
the wavelets, which reflects prior knowledge that frequency-domain NMR spectra lie205
almost completely in the upper-half of the (x, y) plane.206
To overcome the strong posterior correlation between parameters corresponding207
to the two model components we introduce purposely designed Metropolis-Hastings208
block proposals which update the parameters of the two components jointly.209
2. MODELLING210
2.1 NMR Spectra211
Previous authors (Bretthorst (1990a), Dou and Hodgson (1996), Rubtsov and Griffin212
(2007)) developed Bayesian models for NMR data in the time domain, in which213
resonance signals appear as exponentially decaying sinusoids. However, we prefer214
to model conventionally preprocessed (by apodization, phase and baseline correction)215
data in the more interpretable frequency domain, in which resonance signals appear as216
peaks (e.g. Figure 1). Our model exploits the positivity of the frequency-spectrum, a217
condition which cannot be expressed parsimoniously in the time domain. Under an iid218
Gaussian model for errors, the two representations contain the same information since219
they are related by an orthogonal transformation (the discrete Fourier transform).220
A frequency domain NMR dataset is a pair (x,y), where x is a length n vector221
of points on the chemical shift axis, usually regularly spaced and y is a vector of222
corresponding resonance intensity measurements. n is typically of the order 103 to223
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104 depending on the resolution of the spectrum, and the size of the region under224
consideration. The intensity measurements are noisy, so that, although they measure225
inherently positive quantities, some components of y are likely to fall below the δ-axis.226
y is usually standardized in some way, for example so that
∑n
i yi = 1.227
We model y|x assuming the yi|x are independent normal random variables and,
E (yi|x) = φ(xi) + ξ(xi) (2)
where the φ component of the model represents signal from metabolites with peaks228
we wish to assign explicitly and which have been previously characterized and cat-229
aloged in databases. (The metabolites chosen will vary from analysis to analysis230
according to the prior belief about the content of the biological mixture and the sci-231
entific question.) The ξ component of the model represents signal generated by peaks232
we do not wish to assign (this may include signal from uncataloged resonances of233
molecules which are partially characterized, with the characterized resonances mod-234
eled in the φ component). We construct φ parametrically (as a continuous function235
of continuous chemical shift δ) using the physical theory of NMR, and we model ξ236
semi-parametrically using wavelets.237
2.2 Modeling φ, the cataloged metabolite signal238
According to physics, the resonance signatures of distinct compounds are indepen-239
dent, accumulate with an intensity proportional to molecular abundance and aggre-240
gate in a spectrum by convolution. Consequently, we can write φ as a linear combina-241
tion, where each term in the sum corresponds to the signature of one of M different242
metabolites,243
φ(δ) =
M∑
m=1
tm(δ)βm. (3)
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(The value of M will depend on the scientific problem, it is likely to be of order 100244
to 102). For each m, tm is a continuous template function which specifies the NMR245
signature of metabolite m. The corresponding coefficient βm is proportional to the246
molecular abundance of m (i.e. the concentration of m) in the biological sample.247
Physical theory restricts the model space for each template function to a parametric248
mixture of horizontally translated and vertically scaled Lorentzian peaks (Hore 1995).249
We remarked previously that many metabolite signatures contain clusters of Lorentzian250
peaks called multiplets. Isolated peaks are often classed as singlet multiplets and, if251
we adopt this convention, we can express each signature template tm completely as a252
linear combination of a set of multiplet curves gmu,253
tm(δ) =
∑
u
zmugmu(δ − δ
⋆
mu), (4)
where u is an index running over all the multiplets belonging to metabolite m. We254
assume
∫∞
0
gmu(δ)dδ =
∫
0
−∞
gmu(δ)dδ for all m, u, so that the parameter δ
⋆
mu specifies255
the position on the chemical shift axis of the center of mass of the uth multiplet of256
the mth metabolite (see the large multiplet in Figure 4). We call δ⋆mu the chemical257
shift parameter of the multiplet. Each of the coefficients zmu is a positive quantity,258
usually equal to the number of protons in a molecule of m that contribute resonance259
signal to the multiplet u. (zmu may sometimes be non-integral, due for example to260
relaxation effects (Hore 1995). In these cases zmu must be interpreted as an ‘effective’261
proton contribution).
∫∞
−∞
gmu(δ)dδ is constant over m and u so the area under each262
tm is proportional to
∑
u zmu, the number of protons resonating in a molecule of m.263
With a few exceptions, multiplets can be classified into one of a number of com-264
mon types (Figure 4) which determine the configuration of the peaks (a doublet, a265
triplet, a doublet of doublets, etc). This classification together with a small number of266
continuous quantities called J-coupling constants, which determine the (horizontal)267
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distances between the peaks, completely parameterize a multiplet curve.268
[Figure 4 about here.]269
To be precise, a multiplet curve gmu is the weighted average of Vmu translated
Lorentzian curves (see eqn. (1)),
gmu(δ) =
Vmu∑
v=1
wmuvlγ(δ − cmuv), (5)
where the weights wmuv (which sum to one over v) determine the relative heights of270
the peaks of the multiplet and the translations cmuv determine the horizontal offsets271
of the peaks from the center of mass of the multiplet (see Figure 4). Multiplets are272
(usually) symmetric so that {−cmuv : v = 1, ..., Vmu} = {cmuv : v = 1, ..., Vmu} and273
wmuv′ = wmuv when cmuv′=−cmuv.274
2.3 Modeling ξ, the uncatalogued metabolite signal275
We model (ξ(x1), ..., ξ(xn))
T as a linear combination of wavelet basis functions and276
use θ to denote the vector of wavelet coefficients. We chose to use Daubechies’s277
least asymmetric wavelets with 6 vanishing moments (symlet-6) as a wavelet basis278
because these wavelets have a similar shape to Lorentzian peaks. Symlets have been279
used previously to select features from NMR spectra (Kim et al. 2008) and sensitivity280
analysis comparing other potential wavelet bases showed little difference in spectral281
reconstructions.282
2.4 The Likelihood283
We now bring together the models for φ and ξ to make a formal specification of the
probability model for the data. It is easier to do this in the wavelet domain, because
the dimension of the wavelet space p often needs to be greater than the dimension
of the data space n, to deal with distortion at the spectral borders (see Strang and
10
Nguyen (1996) and Section 1 of the supplementary material.) Let W be the wavelet
transform corresponding to the symlet-6 wavelet basis. The likelihood, is defined by
Wy =WTβ + Ipθ + ǫ, ǫ ∼ N(0, Ip/λ), (6)
where T is the n×M matrix with tm(xi) as its (i,m)th entry, Ip is the p× p identity284
matrix and where λ is a scalar precision parameter.285
Equation (6) is a linear regression of Wy on the columns of [WT Ip], the matrix286
generated by adjoining WT and Ip columnwise. Since this matrix has more columns287
than rows, the regression coefficients cannot all be identifiable in the likelihood. We288
address this in the next section, by specifying a prior which helps to distinguish the289
parametric and semi-parametric components of the model.290
2.5 Prior specification291
Our aim is to obtain a joint Bayesian posterior distribution over the parameters con-292
trolling the shape of the templates {tm : m = 1, ...,M}, and the regression parameters293
β, θ and λ; we now specify priors for these parameters.294
Prior for the peak-width: Our focus is on spectra generated by biofluids such as cell295
supernatants or urine, for which peak-widths vary between, but negligibly within296
spectra; it is therefore reasonable to assume that peaks within a spectrum depend on297
a single common peak-width parameter γ. Our prior for γ is a log-normal distribution,298
with Median(γ) = 1Hz/F , Var(γ) = 4.6Hz2/F 2 where F is the operating frequency299
of the spectrometer in MHz. This prior gives good support to a broad region around300
1Hz/F , typical of the peak-widths generated by modern spectrometers (Hore 1995).301
(With this prior, it is easy to relax the assumption of a common peak-width, since302
local deviations at the metabolite, multiplet, or peak level can be modelled using303
Gaussian random effects on log(γ).)304
11
Prior for the multiplets: In section 2.2 we described a two-level parameterization of305
metabolite signature templates, defined by (4) and (5), as a linear combination of306
Lorentzian peaks nested in multiplets. This allows us to represent a difference in307
the uncertainty of peak positions within and between multiplets. The parameters308
cmuv and wmuv, which determine the multiplet shapes, vary very little across NMR309
spectra. We assume they are constant and compute them by applying some simple310
rules (see Hore (1995), chap. 3 for the details), from empirical estimates of the J-311
coupling constants which are published in online databases. In contrast, as noted in312
section 1.2, the multiplet chemical shift parameters δ⋆mu do fluctuate slightly between313
spectra according to experimental conditions. We use an estimate δˆ⋆mu of each δ
⋆
mu,314
taken from online databases, to construct an informative prior which accounts for this315
uncertainty. The positional noise is local and smaller fluctuations are more probable316
than larger ones, so we assign each δ⋆mu a truncated normal prior distribution with317
mean parameter δˆ⋆mu, variance parameter 10
−4ppm2 and truncation region [δˆ⋆mu −318
0.03ppm, δˆ⋆mu + 0.03ppm]. It may sometimes be appropriate to specify a multiplet319
or metabolite specific alternative depending on what is known about the variability320
of particular multiplet locations across spectra.321
Prior for the metabolite abundances: Having defined a parametric prior for the322
metabolite signature templates, we now consider the prior for the vector β, each323
component of which represents the resonance intensity of a signature and is propor-324
tional to the abundance of that metabolite in the biological sample. The intensities325
are positive so the prior for each component of β should confine its support to R+.326
For conditional conjugacy, we assign a normal prior to each βm, truncated below at327
zero, βm ∼ TN(em, 1/sm, 0,∞). This is flexible enough to encode prior information328
for a wide range of research problems. For the simulations and examples presented329
in this paper we assume low prior information and choose em = 0 and sm = 10
−3 for330
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all m.331
Prior for the wavelet coefficients and precision parameter: In section 2.4 we observed332
that the parametric (φ) and semi-parametric (ξ) components of the model are not333
identifiable in the likelihood. In order to resolve the model components we penalize the334
semi-parametric component by assigning the wavelet coefficients a prior distribution335
with heavy tails and a concentration of probability mass near zero. In addition, to336
reflect prior-knowledge that NMR spectra are mostly restricted to the half-plane above337
the chemical shift axis, our prior penalizes models in which W−1θ has components338
below a small negative threshold. To be precise, in order to specify a joint prior339
for (θ, λ) we introduce a vector of hyper-parameters ψ, each component of which340
corresponds to a wavelet and a vector of hyper-parameters τ , each component of341
which corresponds to a spectral data point. The joint prior for (θ,ψ, τ , λ) has pdf342
proportional to343
λa+
p+n
2
−1
[∏
jk
ψ
cj−1/2
jk exp
(
−
ψjkdj
2
)]
exp
(
−
λ
2
(
b+
∑
jk
ψjkθ
2
jk + r (τ − h1n)
2
))
1{W−1θ≥τ∧h1n≥τ}
(7)
The index jk here corresponds to the kth wavelet in the jth wavelet-scaling level.344
The following lemma is proved in the supplementary material345
Lemma 1 Normalization of (7) defines a joint prior for (θ,ψ, τ , λ). This prior is346
proper.347
The joint prior specified by (7) was motivated by consideration of a scale mixture348
of multivariate normals with smoothed truncation limits:349
P (θ|ψ, τ , λ) =
λp/2
∏
jk ψ
1/2
jk
Cψτλ
exp
(
−
1
2
∑
jk
λψjkθ
2
jk
)
1{W−1θ≥τ}, (8)
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ψjk ∼ Gamma(cj, dj/2), (9)
τi ∼ TN(h, 1/(λr),−∞, h), (10)
λ ∼ Gamma(a, b/2), (11)
where Cψτλ is a normalizing constant. The index i here corresponds to the ith350
spectral data point. In this specification, ψ allows the prior precision associated351
with each wavelet to deviate from the global precision λ. The gamma hyperprior352
on each component of ψ induces local shrinkage in the marginal prior for θ, which353
encourages posterior sparsity in the wavelet coefficients. τ is a vector of n truncation354
limits, which bounds W−1θ below. The decaying hyperpriors on the components of355
τ smooth these limits and penalize θ more heavily as more of the semi-parametric356
component (ξ component) of the model lies below the line y = h, where h is a small357
negative number, chosen close to zero on the spectral intensity scale.358
The joint distribution specified by (8)-(10) is a reasonable representation of prior359
belief about θ and λ; it places a constraint on the conditional distribution of θ given360
ψ, τ and λ. However, because the normalizing constant Cλψτ of (8) has no closed361
form, it is hard to devise a computationally efficient scheme to sample from the362
resulting ‘doubly intractable’ posterior (Murray et al. 2006). The prior defined by363
(7) places the constraint on the joint distribution of the parameters, rather than the364
conditional distribution and it is easy to sample from the full conditionals of θ, ψ,365
τ and λ, if we use this prior. We contend that this is an equally valid specification366
and show in Section 2 of the supplementary material that it behaves similarly to the367
prior defined by (8)-(10).368
Figure 5 demonstrates the effect of penalizing the semi-parametric component of369
the model when it lies below the chemical shift axis. First, without penalizing ξ in the370
lower half plane, if the components of θ are given untruncated Student’s-t priors, the371
posterior for the vector of quantification parameters β focuses asymptomatically on a372
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region close to the ordinary least squares estimate of the parameters, (TTT)−1TTy,373
while the wavelet component absorbs most of the residual spectrum. When a metabo-374
lite has a multiplet embedded in a region of unassigned spectral resonance the least375
squares estimate overestimates the corresponding quantification parameter. The sig-376
nature templates absorb spectral signal even when they do not match the shape of the377
spectral data and this leads to strong posterior support for negative values for some378
components of W−1θ. The prior defined by (7) however, can correct the concentra-379
tion estimate providing at least one of the multiplets of the metabolite is deconvolved380
cleanly.381
[Figure 5 about here.]382
Scale-invariant inference and hyper parameter settings: Note that in the limit a →383
0, b → 0, ∀m, sm → 0, the (improper) prior is invariant under the scaling reparame-384
terisation (β, θ, λ) 7→ (Sβ, Sθ, λ/S2) for every constant S > 0 so that, in this limit,385
inference is unaffected by the scale of measurement of the data. Smaller a and b386
correspond to increased uncertainty in the value of λ. For simulations and examples387
described in this paper we take a = 10−9 and b = 10−6.388
The values of the cj and dj control the degree of shrinkage penalization imposed on389
the wavelet coefficients. Experience shows cj = 0.05 and dj = 10
−8 provides adequate390
penalisation. More stringent penalization is possible but our MCMC algorithm tends391
to mix less well as the penalty gets stronger, because our block updates are less good392
at targeting the true posterior distribution of θ (see below). h controls the threshold393
below which the wavelets are penalised in the lower half plane while r controls the394
strength of that penalisation. We choose h a little below zero to be sure that true395
signals below y = 0, due for example to baseline wiggle can be adequately modelled396
by wavelets. We set h = −0.002 and r = 105.397
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3. MARKOV CHAIN MONTE CARLO ALGORITHM398
We implemented a Markov chain Monte Carlo algorithm, to sample from the joint399
posterior distribution of the model parameters. There are three types of MCMC400
update.401
• Firstly, there are Gibbs samplers for the components of β (truncated normal),402
the components of θ (truncated normal), the components of ψ (gamma), the403
components of τ (truncated normal) and λ (gamma). The specific distributions404
for these updates are given in the supplementary material.405
• Secondly, there is a Metropolis-Hastings update for each of the parameters (ex-406
cept the components of β) controlling the parametric component of the model.407
Specifically, in order to update the multiplet chemical shift parameter δ⋆mu we
propose δ⋆mu
′ from
TN(δ⋆mu, V
2
δ⋆mu
δˆ⋆mu − 0.03ppm, δˆ⋆mu + 0.03ppm), (12)
a Gaussian proposal, centred on the current parameter value and truncated at408
the boundaries of the prior distributions. We adapt the proposal variance V 2δ⋆mu409
using the Adaptive Metropolis-within-Gibbs algorithm of Roberts and Rosen-410
thal (2009). Vδ⋆mu is tuned to target an acceptance rate of 0.44 by increments411
and decrements which decay in magnitude asymptotically like the inverse of the412
square root of the iteration number.413
In order to update the peak-width parameter we make a Gaussian proposal for414
log γ, centred on the current parameter value. Again, we adapt the proposal415
variance following Roberts and Rosenthal (2009).416
The likelihood constrainsWy−WTβ−θ, inducing strong posterior correlation417
between the parametric and semi-parametric components of the model. Con-418
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sequently, updates of this type, which just propose changes to the parametric419
component, can only make local moves in the state space of the Markov chain.420
• Thirdly, there are Metropolis-Hastings block updates in each of which a param-421
eter controlling the parametric component of the model is updated jointly with422
the vector θ of wavelet coefficients. The joint proposal breaks the posterior423
correlation between the parametric and semi-parametric model components,424
allowing larger jumps in state-space.425
Block updates of the δ⋆mu extend the univariate proposals described previously.426
First we draw the univariate proposal δ′⋆mu (although we fix the proposal vari-427
ance, see supplementary material), then conditional on the value drawn we428
propose a new value θ′ for the vector of wavelet coefficients θ and perform a429
global Metropolis-Hastings accept-reject assessment for the block update.430
The conditional proposal for θ′ is a multivariate truncated normal distribution431
with mean parameterWy−WT′β (where T′ is the template matrix updated to432
reflect the initial univariate proposal), precision parameter λIp and truncation433
W−1θ′ ≥ τ . We can simulate from this distribution by making the change434
of basis, η′ = W−1θ′; the components of η′ are then independent univariate435
truncated normal distributions. This choice of conditional proposal is motivated436
by the full conditional of θ,437
θ|ψ, τ , λ,y ∼ TMV N
(
Wy −WTβ, (Ip +Ψ)
−1 /λ,W−1θ ≥ τ
)
(13)
which has a similar distribution but with a reduced precision. Unfortunately438
there is no easy way to sample from (13) because the truncation condition439
W−1θ ≥ τ induces a complex dependence structure between the components440
of θ.441
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The only proposals not yet described are those for the block updates of each442
component of β with θ. We propose β ′m from a Cauchy distribution, truncated443
below at zero. We center the Cauchy distribution on the point that maximizes444
the full conditional of βm subject to θ = 0 and to the truncation condition445
y−Tβ > τ . This is a greedy proposal, in the sense that it attempts to maximise446
β ′m and explain as much of the spectral signal as possible using the template447
for metabolite m, excluding the wavelets (θ = 0). Conditional on the proposed448
β ′m we propose θ
′ from a multivariate truncated normal distribution with mean449
parameter Wy − WTβ′ (where β′ is β with the mth component set to β ′m),450
precision parameter λIp and truncation W
−1θ′ ≥ τ .451
Although, on average, block updates move the chain further than the correspond-452
ing single parameter updates, the acceptance rate is lower. Consequently moves of453
the second and third type make complementary contributions to MCMC mixing.454
Improving convergence and mixing: During the burn in stage of the MCMC we tem-455
per the likelihood and penalize the wavelet component of the model stringently to help456
the chain move into a region of good posterior support. A parameter T (see section457
2 of supplementary material), which jointly controls the temperature/penalization,458
gradually cools according to a deterministic schedule, proportional to the complement459
of a Gaussian cdf.460
To improve mixing, we implemented a population (multi-chain) version of our461
algorithm in which the MCMC operates on a product state-space composed of copies462
of the space described in Section 2. The chain targets a tempered version of the463
posterior distribution of interest marginally on each subspace, but with each subspace464
taking a different value of T . The Metropolis-Hastings updates already described465
operate within each subspace; the acceptance probabilities for these depend only on466
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the state of the relevant subchain and so they can be carried out in parallel on different467
CPU cores. Additionally, there are two types of update which allow the transfer of468
information between subspaces. Firstly, we propose that subspaces adjacent in the469
ordering of T swap parameter values, as in the exchange moves of parallel tempering470
(Geyer 1991). Secondly, for a multiplet location parameter δ⋆mu in a given subchain,471
we pick a complementary subchain uniformly at random and propose a new value472
for δ⋆mu from a Cauchy distribution, centred on the value of the parameter in the473
complementary chain, with scale-parameter 3ppm. We then propose a conditional474
update for the θ of the given subchain in the manner of the block-updates already475
described. This proposal is made for every chemical shift parameter of every subchain476
once for each iteration of the MCMC algorithm. It allows good values of a chemical477
shift parameter to spread through the population of chains. In principle additional478
information sharing moves (e.g. Evolutionary Monte Carlo crossover (Liang and479
Wong 2000)) could be added, but we find this ‘copy’ move to be sufficient. Ergodicity480
and the marginal convergence of the subchain with T = 1 to a stationary distribution481
equal to the target posterior is assured by theory (Jasra, Stephens and Holmes 2007).482
We combine annealing with parallel chains by running a ladder in which the ratios of483
the temperatures of the subchains are constant over time, and for which the target484
subchain (that with T = 1) cools according to the specified annealing schedule.485
4. PERFORMANCE486
We simulated 100 biofluid NMR spectra by convolving the standard library spec-487
tra for pure samples of acetic acid, alanine, betaine, creatine, glycine, glycolic acid,488
guanidoacetic acid, lactic acid, succinic acid, taurine, trimethylamine and trimethy-489
lamine oxide all of which generate resonances in the region 0ppm − 5ppm. The490
concentration of each metabolite was generated as a U [0, 1] random variable and the491
multiplets of each metabolite were perturbed by draws from U [−0.03ppm, 0.03ppm].492
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We mixed each simulated spectrum with a broad Gaussian pdf the mean of which493
was drawn uniformly from the range of the spectrum (0ppm − 5ppm) and standard494
deviation of which was fixed at 5.8ppm. This hump is typical of the broad baseline495
distortions commonly generated by macromolecules in biofluid spectra.496
Because each spectrum in the standard library was generated from a different 1H497
NMR experiment, the width of the peaks in a simulated spectrum can vary slightly498
between resonances generated by different compounds. This variability can affect499
inferences of concentration made with our model because of correlation between con-500
centration and peak-width parameters. To deal with this artefact of the simulator,501
we extended the model by adding random effects to allow for some (small) inter-502
metabolite variability in the peak-width.503
We applied the (single chain version of the) MCMC algorithm for the extended504
model to each simulated spectrum, running for 5 000 iterations with a 3000 iteration505
burn in.506
4.1 Multiplet Localization507
Figure 6 is a normalised histogram of the difference between the Bayesian poste-508
rior mean estimate of each multiplet chemical shift and the true simulated chemical509
shift, illustrating the quality of the peak localisation. The Bayesian posterior mean510
estimates 85% of shifts within 0.002ppm and 90% within 0.015ppm.511
[Figure 6 about here.]512
4.2 Quantification513
We compared our Bayesian method for quantification to the following algorithm for514
numerical integration, which is slightly more sophisticated than conventional spectral515
binning because it includes a peak identification step. To integrate a multiplet we used516
the known simulated perturbation in chemical shift to identify the precise location of517
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the multiplet. In practice, this information would be unknown to a spectroscopist, at518
best he or she might be able to identify a multiplet by eye and choose bin boundaries519
based on the observed location. The information is, of course, unavailable to the520
Bayesian method. Using the pure compound spectrum we identified the region [L,R]521
of the chemical shift axis that corresponds to the central 95% mass of the multiplet’s522
parametric template. Finally, we estimated the total area under the multiplet by523 (∑
L<xi<R
yi
)
/(0.95N(L− R)), where N is the number of xi in [L,R].524
The plots in Figure 7 show the actual vs. estimated concentrations for estimates525
made by numerical integration and Bayesian posterior mean. The numerical method526
is systematically biased towards overestimation for two reasons. Firstly, it fails to527
take account of the Gaussian background hump and secondly it cannot distinguish528
resonance in the region [L,R] generated by the metabolite of interest from other con-529
founding signals. The Bayesian estimate is unaffected by the first problem because530
the background hump is modeled with wavelets; the second problem is dealt with531
by deconvolution. The mean quadratic error for the numerical estimator is 0.106532
(equivalent to Pearson correlation 0.70), where the mean is taken over all simulation533
replicates and metabolites. In comparison, the quadratic error for the Bayesian pos-534
terior estimator is 0.017 (equivalent to Pearson correlation 0.89), over sixfold smaller.535
[Figure 7 about here.]536
To investigate the performance of the Bayesian method under different strengths537
of multiplet chemical shift perturbation we ran an additional 150 replicates of the538
simulations previously described in 3 blocks of 50 with perturbations drawn from539
U [−0.01ppm, 0.01ppm], U [−0.02ppm, 0.02ppm] and U [−0.04ppm, 0.04ppm] in each540
block. We extended the truncation on the chemical shift priors to ±0.045ppm the541
database estimate. The peak assignments and concentration estimation errors are542
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summarized in Table 1. There is no evidence of a major trend in the quality of peak543
assignment or concentration estimation with the magnitude of multiplet perturbation.544
[Table 1 about here.]545
5. YEAST DATASET546
To illustrate the performance of our method on a real dataset, we took three spectra547
from the experiment investigating the metabolic response of the yeast Pichia pastoris548
to recombinant protein expression (Tredwell, Edwards-Jones, Leak and Bundy 2011).549
The spectra were generated using biological replicates prepared under the same con-550
ditions. Consequently, the metabolic profiles of the samples are extremely similar551
and the spectra contain essentially the same metabolite concentration information.552
Nevertheless, the spectra are slightly different, because for example, of experiment553
level positional noise in the chemical shifts of resonance peaks. By modeling the554
three spectra jointly we can quantify metabolites using information from all three555
replicates, while accounting for these experiment level differences.556
We used the model described in Section 2 as a basis for a joint model of multiple557
spectra. In the new model, the vector of metabolite quantification parameters β is558
held in common across the spectra. All the remaining parameters are copied from559
the original model, with a replicate set assigned to each spectrum. The MCMC560
algorithm for the multiple-spectra model is very similar to the procedure described561
for the original model. The Metropolis-Hastings updates involving components of β562
need to be adjusted, to reflect the dependence on multiple spectra, but are similar563
to those for the simpler model (see section 3 of the supplementary material). The564
updates for the remaining parameters continue to be valid within each spectrum565
because, conditional on β, the joint posterior factorizes into separate probability566
models, each corresponding to a different spectrum.567
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Tredwell, Behrends, Geier, Liebeke and Bundy (2011) manually quantified 37568
metabolites from these spectra, with each of the five authors assigning the resonances569
and estimating concentrations independently. Not all the resonance patterns gener-570
ated by the 37 metabolites take the form of the symmetric multiplets described in571
Section 2. Multiplet shapes are sometimes distorted by strong interaction effects,572
which we cannot easily include in our model because they are neither described by573
a known parametric model nor cataloged in a public database. However, distorted574
multiplets are still convolutions of Lorentzian peaks, so it is sometimes possible to575
construct a template-based model by estimating the weights and translations of (5)576
from an NMR spectrum of the relevant pure compound generated under similar ex-577
perimental conditions. We were able to construct a parametric signature template578
for 26 of the 37 compounds by combining public database information with param-579
eter estimates from our laboratory library of pure compound spectra. However, we580
were unable to construct complete signatures, containing a full complement of mul-581
tiplets, for every metabolite. Although this precludes a complete deconvolution of582
the spectral signal generated by compounds with unmodeled resonances, and the583
omitted resonance signals will be absorbed into the wavelet component of the model.584
Nevertheless, our main aim is to obtain accurate concentration estimates and this585
is still achievable, providing at least one multiplet from each metabolite deconvolves586
correctly.587
We ran the MCMC procedure, with 8 parallel chains tempered on a ladder, for588
20 000 iterations following a 10 000 iteration burn in. We made an adjustment589
to the prior on the chemical shift parameters of the singlet multiplets generated590
by Histidinol near to 7.25ppm and 8.19ppm by truncating the prior at ±0.5ppm591
of the HMDB estimate rather than at ±0.03ppm. This represents prior knowledge592
that the chemical shifts of those multiplets are more variable than is typical because593
23
of sensitivity to chemical properties of the biofluid. Figure 8 shows the posterior594
deconvolution of a heavily congested region (2.6ppm−3.1ppm) and a region of broad595
(0.8ppm− 1.4ppm) from one of the spectra.596
The five spectroscopists deconvolved the spectra with the assistance of the widely597
used Chenomx spectrographic software, which implements a form of targeted profil-598
ing (Weljie et al. 2006). This is probably the most precise method currently available599
for estimating metabolite concentrations from spectra, although its accuracy depends600
on spectroscopists being able to make correct peak assignments. Figure 9 is a plot601
showing the strong concordance between the concentration estimates of the spectro-602
scopists and concentration estimates made by the Bayes posterior mean. Although603
11 of the 26 posterior mean estimates lie outside the range of the spectroscopists’604
estimates, there are only 3 cases of substantial discordance. The statistical estimates605
for arginine and histidinol are substantially larger than the spectroscopist’s estimates606
while that for malic acid is substantially lower. In the cases of arginine and histidinol607
it is hard to fault the posterior deconvolution by visual inspection. The discrepancies608
could be due to an error in the templates used by the spectroscopists to profile the609
resonances or to experimental errors in the database estimates of the parameters used610
to construct the metabolite signature templates of Bayesian model. In the case of611
malate the discrepancy appears to have been caused by a multiplet misalignment. In612
principle this could be resolved by adjusting the prior for that multiplet’s chemical613
shift parameter in order to force the correct alignment.614
[Figure 8 about here.]615
[Figure 9 about here.]616
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6. DISCUSSION617
Presently, automatic methods for analyzing biofluid NMR data rely on non-parametric618
pattern recognition techniques or are based on approximate numerical integration619
algorithms, such as spectral binning. These methods ignore a large amount prior620
information about the physical process generating the spectral data.621
Prior information about a data generating process can easily be incorporated into622
a Bayesian analysis through specification of a likelihood and specification of a prior623
distribution for the parameters of the likelihood. We have shown that a Bayesian624
model for biofluid spectra, which exploits an informative parametric prior for the625
patterns of resonance generated by selected metabolites, can be used to deconvolve626
those resonances from a spectrum and to obtain explicit concentration estimates for627
the metabolites.628
Simulations show that our MCMC algorithm usually identifies spectral resonance629
peaks precisely. Peak misalignment may occur when a target resonance for a multi-630
plet of a template appears in the spectrum close to other stronger signals. The model631
may then encourage the template to align incorrectly with the stronger signals, even632
if they have the wrong shape. This is because the wavelet coefficients are heavily633
penalized in the prior but the parametric templates are not. Even when the model634
posterior concentrates around an incorrect deconvolution, the strong prior penaliza-635
tion on negative spectral signal means that posterior estimates of concentration can636
still be accurate, providing at least one multiplet for each metabolite deconvolves cor-637
rectly. Concentration estimation, the main motivation for the modeling, is therefore638
quite robust to mis-assignment of spectral resonances.639
It is worth noting that resonance mis-assignment is a problem for all methods,640
(including manual assignment by an expert; it is unavoidable for binning methods641
when peaks overlap) and our approach suggests two methods for resolving mistakes.642
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Firstly, signature templates corresponding to the compounds generating confounding643
signals can be added to the parametric component of the model (providing they are644
available). Secondly, the prior on the chemical shift parameter can be adjusted to fix645
the position of a misaligned multiplet.646
Our approach yields improved concentration estimates. A comparison with a647
method for quantifying metabolites based on numerical integration shows the poste-648
rior mean estimates of the Bayesian model to be 6 fold more accurate in quadratic649
error, even when exact multiplet locations are given to the numerical integration650
algorithm.651
We are able to fit M = 20 metabolites to an n = 3 000 datapoint spectrum in652
about 60 minutes on a 2.2GHz desktop machine using less than 0.5GB of RAM when653
running the MCMC algorithm for 10 000 iterations. (If multiple chains are required654
to improve mixing, they will run in parallel on a multicore machine.) The number655
of operations required by the MCMC algorithm is linear in n and M . The memory656
requirement is linear in the number of MCMC iterations and quadratic in n. This rate657
of computation can easily compete with the rate of acquisition of spectra by a typical658
NMR laboratory, effectively removing a major bottleneck in laboratory pipelines.659
An accurate, automatic method for estimating metabolite concentrations from660
1H-NMR spectra will assist many research projects in metabolomics. The field relies661
heavily on NMR for metabolite quantification and currently, even projects analyz-662
ing a few tens of spectra use numerical integration for estimation. Bayesian model-663
ing should become increasingly useful as prior information on metabolite resonance664
patterns becomes more accurate and extensive. For example, with more detailed665
information our template model could be extended to deal systematically with the666
effects of interactions between multiplets. We plan to develop our model further and667
to release an efficient implementation of our methodology capable of simultaneously668
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deconvolving the majority of metabolites assignable in the NMR spectra of complex669
biological mixtures.1670
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Figure 1: A section from an NMR spectrum from an experiment investigating protein
expression in yeast. The x-axis measures chemical shift in parts per million (ppm).
The y-axis measures relative resonance intensity.
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Figure 2: An 1H NMR spectrum (top panel) with the principal resonance signals
deconvolved into the metabolite NMR signatures (lower panels) of (in descending
order by panel) citric acid, 2-oxoglutaric acid, taurine and trimethylamine N-oxide.
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Figure 3: Positional noise between, and peak overlap within, two NMR spectra taken
from the yeast experiment; resonances are generated by alanine (left) and threonine
(right).
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Figure 4: The peak configurations of some common types of multiplet. Top row :
a doublet, with chemical shift δ⋆mu and peak offset cmuv. Middle row : (from left to
right) a singlet, a triplet, a quadruplet. Bottom row : (from left to right) a quintuplet,
a doublet of doublets and a triplet of doublets.
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Figure 5: The effect of a prior penalizing the ξ component of the likelihood in the lower
half plane (top) compared to one without this penalization (bottom). The dashed lines
show the spectral data. Deconvolution of a parametric metabolite signature template
(heavy lines, left) can be more accurate when the wavelet component (heavy lines,
right) is penalized below the δ-axis.
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Figure 6: Normalized histogram of simulated minus Bayesian posterior mean esti-
mates of multiplet shift.
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Figure 7: Concentration estimates from simulated spectra: true vs estimated con-
centrations for numerical integration (left) and for Bayesian posterior mean (right).
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Figure 8: Deconvolution of selected regions from one of the yeast spectra. The top
panel shows resonances generated by isoleucine (NW-SE hatch), leucine (NE-SW
hatch), threonine (vertical hatch) and valine (horizontal hatch). The lower panel
shows resonances generated by aspartate (NW-SE hatch), asparagine (black shade),
histidinol (vertical hatch), lysine (horizontal hatch), malate (NE-SW hatch) and me-
thionine sulfoxide (grey shade). The deconvolution is conditional on the MAP esti-
mates of the peak-width and chemical shift parameters and plotted on the same grid
as the original spectrum. The original spectral data is shown by the continuous lines
and the wavelet component of the model by the dashed lines.
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Figure 9: Comparison of metabolite concentration estimates by posterior mean of
the quantification parameters from the Bayesian model (y-axis) with manual spec-
troscopists estimates (x-axis). The scales are calibrated so that the concentration of
Trehalose is equal to 1. Each circle represents the mean of the five spectroscopists
estimates while the limits of the horizontal bars represent the range. The inset is a
magnification of the region bounded by the dashed line.
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Table 1: Peak assignment and concentration estimation errors for different magni-
tudes of simulated chemical shift perturbation.
Distribution of Simu-
lated Perturbations
Peaks Assigned
Within 0.002ppm
Mean Quadratic
Error for Bayes
Estimate
Mean Quadratic
Error for Numer-
ical Integration
Estimate
U [−0.01ppm, 0.01ppm] 83% 0.016 0.141
U [−0.02ppm, 0.02ppm] 84% 0.016 0.102
U [−0.04ppm, 0.04ppm] 83% 0.017 0.135
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